Patents Assigned to INTERPACE DIAGNOSTICS CORPORATION
  • Methods for treating Barrett's metaplasia and esophageal adenocarcinoma
    Patent number: 12205676
    Abstract: Disclosed herein are methods for treating Barrett's metaplasia and esophageal adenocarcinoma and methods for determining mutational load as a predictor of the risk of disease progression from Barrett's metaplasia to esophageal adenocarcinoma.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: January 21, 2025
    Assignee: Interpace Diagnostics Corporation
    Inventors: Eric Matthew Gayle Ellsworth, Sydney David Finkelstein, Sara Ann Jackson, Brendan Corcoran, Dennis Morgan Smith
  • Topographic genotyping for determining the diagnosis, malignant potential, and biologic behavior of pancreatic cysts and related conditions
    Patent number: 11143657
    Abstract: The application relates to a method of a predicting the presence of invasive pancreatic cancer or high grade dysplasia, pre-cancerous pancreatic states and non-neoplastic conditions comprising detailed molecular analysis incorporating DNA quality and quantity, K-ras mutational analysis and a broad spectrum of tumor suppressor gene linked microsatellite LOH. Methods of diagnosing, determining prognosis of and determining a course of treatment for pancreatic cancer or high grade dysplasia, pre-cancerous pancreatic states and non-neoplastic conditions are also provided.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: October 12, 2021
    Assignee: Interpace Diagnostics Corporation
    Inventors: Sydney David Finkelstein, Patricia Swalsky
  • Methods for measuring carcinoembryonic antigen
    Patent number: 10444239
    Abstract: Disclosed herein are methods of accurately measuring carcinoembryonic antigen in a biological sample and methods of identifying and treating a mucinous cyst in a subject.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: October 15, 2019
    Assignee: INTERPACE DIAGNOSTICS CORPORATION
    Inventors: Sydney David Finkelstein, Sara Ann Jackson, Jamie Michelle Bleicher, Eric Matthew Gayle Ellsworth, Dennis Morgan Smith, Jr.
  • Methods for treating Barrett's metaplasia and esophageal adenocarcinoma
    Patent number: 10255410
    Abstract: Disclosed herein are methods for treating Barrett's metaplasia and esophageal adenocarcinoma and methods for determining mutational load as a predictor of the risk of disease progression from Barrett's metaplasia to esophageal adenocarcinoma.
    Type: Grant
    Filed: December 3, 2012
    Date of Patent: April 9, 2019
    Assignee: INTERPACE DIAGNOSTICS CORPORATION
    Inventors: Eric Matthew Gayle Ellsworth, Sydney David Finkelstein, Sara Ann Jackson, Brendan Corcoran, Dennis Morgan Smith, Jr.
  • Methods for treating barrett's metaplasia and esophageal adenocarcinoma
    Patent number: 10131942
    Abstract: Disclosed herein are methods for treating Barrett's metaplasia and esophageal adenocarcinoma and methods for determining mutational load as a predictor of the risk of disease progression from Barrett's metaplasia to esophageal adenocarcinoma.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: November 20, 2018
    Assignee: INTERPACE DIAGNOSTICS CORPORATION
    Inventors: Eric Matthew Gayle Ellsworth, Sydney David Finkelstein, Sara Ann Jackson, Brendan Corcoran, Dennis Morgan Smith, Jr.
  • Methods for measuring carcinoembryonic antigen
    Patent number: 9341628
    Abstract: Disclosed herein are methods of accurately measuring carcinoembryonic antigen in a biological sample and methods of identifying and treating a mucinous cyst in a subject.
    Type: Grant
    Filed: November 27, 2013
    Date of Patent: May 17, 2016
    Assignee: INTERPACE DIAGNOSTICS CORPORATION
    Inventors: Sydney David Finkelstein, Sara Ann Jackson, Jamie Michelle Bleicher, Eric Matthew Gayle Ellsworth, Dennis Morgan Smith, Jr.